# Chemo-free in Older (≥65) Node-Positive ER+/HER2- Breast Cancer

> **NCT07005557** · PHASE3 · NOT_YET_RECRUITING · sponsor: **Fudan University** · enrollment: 1244 (estimated)

## Conditions studied

- Breast Cancer
- Adjuvant Therapy

## Interventions

- **DRUG:** Chemotherapy
- **DRUG:** CDK4/6 Inhibitor
- **DRUG:** Endocrine therapy

## Key facts

- **NCT ID:** NCT07005557
- **Lead sponsor:** Fudan University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-06-15
- **Primary completion:** 2030-05-15
- **Final completion:** 2035-05-15
- **Target enrollment:** 1244 (ESTIMATED)
- **Last updated:** 2025-06-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07005557

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07005557, "Chemo-free in Older (≥65) Node-Positive ER+/HER2- Breast Cancer". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07005557. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*